Delaney Mark E's Form 4 filing
Quest Diagnostics Inc (DGX) · filed May 14, 2025
- Accession no.
- 0001022079-25-000132
- Filed
- May 14, 2025
- Trade date
- May 12-13, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $306.8K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Delaney Mark ECIK 0001955265 | Officer (SVP & Chief Commercial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 12, 2025 | Common Stock | SSaleDisposed | −874 | $175.72 | −$153,579.28 | 8,372 | Direct | |
| May 13, 2025 | Common Stock | SSaleDisposed | −874 | $175.31 | −$153,220.94 | 7,498 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.